These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 20198823)

  • 21. The role of the drebrin/EB3/Cdk5 pathway in dendritic spine plasticity, implications for Alzheimer's disease.
    Gordon-Weeks PR
    Brain Res Bull; 2016 Sep; 126(Pt 3):293-299. PubMed ID: 27365229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's mechanisms in ischemic brain degeneration.
    Pluta R; Ułamek M; Jabłoński M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
    Zilka N; Filipcik P; Koson P; Fialova L; Skrabana R; Zilkova M; Rolkova G; Kontsekova E; Novak M
    FEBS Lett; 2006 Jun; 580(15):3582-8. PubMed ID: 16753151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A compartmental model for activity-dependent dendritic spine branching.
    Verzi DW; Noris OY
    Bull Math Biol; 2009 Jul; 71(5):1048-72. PubMed ID: 19172359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease and Abeta toxicity: from top to bottom.
    Small DH; Mok SS; Bornstein JC
    Nat Rev Neurosci; 2001 Aug; 2(8):595-8. PubMed ID: 11484003
    [No Abstract]   [Full Text] [Related]  

  • 26. Layer-specific alterations to CA1 dendritic spines in a mouse model of Alzheimer's disease.
    Merino-Serrais P; Knafo S; Alonso-Nanclares L; Fernaud-Espinosa I; DeFelipe J
    Hippocampus; 2011 Oct; 21(10):1037-44. PubMed ID: 20848609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease.
    Dickson TC; King CE; McCormack GH; Vickers JC
    Exp Neurol; 1999 Mar; 156(1):100-10. PubMed ID: 10192781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease. A new take on tau.
    Marx J
    Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
    [No Abstract]   [Full Text] [Related]  

  • 29. Microtubular reorganization and dendritic growth response in Alzheimer's disease.
    McKee AC; Kowall NW; Kosik KS
    Ann Neurol; 1989 Nov; 26(5):652-9. PubMed ID: 2817839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic pathology in Alzheimer's disease.
    Baloyannis SJ
    J Neurol Sci; 2009 Aug; 283(1-2):153-7. PubMed ID: 19296966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology.
    Fujii R; Okabe S; Urushido T; Inoue K; Yoshimura A; Tachibana T; Nishikawa T; Hicks GG; Takumi T
    Curr Biol; 2005 Mar; 15(6):587-93. PubMed ID: 15797031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid.
    Hasegawa T
    Med Hypotheses; 2007; 69(5):1135-9. PubMed ID: 17499446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death.
    Leschik J; Welzel A; Weissmann C; Eckert A; Brandt R
    J Neurochem; 2007 Jun; 101(5):1303-15. PubMed ID: 17298384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
    Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
    Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities.
    Dorostkar MM; Zou C; Blazquez-Llorca L; Herms J
    Acta Neuropathol; 2015 Jul; 130(1):1-19. PubMed ID: 26063233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic Microtubules in Alzheimer's Disease: Association with Dendritic Spine Pathology.
    Pchitskaya EI; Zhemkov VA; Bezprozvanny IB
    Biochemistry (Mosc); 2018 Sep; 83(9):1068-1074. PubMed ID: 30472945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aβ-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone D.
    Penazzi L; Tackenberg C; Ghori A; Golovyashkina N; Niewidok B; Selle K; Ballatore C; Smith AB; Bakota L; Brandt R
    Neuropharmacology; 2016 Jun; 105():84-95. PubMed ID: 26772969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Of microtubules and memory: implications for microtubule dynamics in dendrites and spines.
    Dent EW
    Mol Biol Cell; 2017 Jan; 28(1):1-8. PubMed ID: 28035040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synapses and dendritic spines as pathogenic targets in Alzheimer's disease.
    Yu W; Lu B
    Neural Plast; 2012; 2012():247150. PubMed ID: 22474602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.